DEPAKINE: 82 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
82
Total FAERS Reports
2 (2.4%)
Deaths Reported
39
Hospitalizations
82
As Primary/Secondary Suspect
8
Life-Threatening
1
Disabilities
First Report: 199809 · Latest Report: 20140617
What Are the Most Common DEPAKINE Side Effects?
#1 Most Reported
Epilepsy
10 reports (12.2%)
#2 Most Reported
Coma
8 reports (9.8%)
#3 Most Reported
Pyrexia
7 reports (8.5%)
All DEPAKINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Epilepsy | 10 | 12.2% | 0 | 2 |
| Coma | 8 | 9.8% | 0 | 1 |
| Drug abuse | 7 | 8.5% | 0 | 3 |
| Pyrexia | 7 | 8.5% | 0 | 4 |
| Convulsion | 6 | 7.3% | 0 | 1 |
| Thrombocytopenia | 6 | 7.3% | 0 | 6 |
| Drug ineffective | 5 | 6.1% | 0 | 0 |
| Tremor | 5 | 6.1% | 0 | 1 |
Who Reports DEPAKINE Side Effects? Age & Gender Data
Average age: 33.7 years. Most reports from: FR. View detailed demographics →
Is DEPAKINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2006 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 1 |
| 2013 | 35 | 1 | 18 |
| 2014 | 22 | 0 | 12 |
What Is DEPAKINE Used For?
| Indication | Reports |
|---|---|
| Epilepsy | 27 |
| Product used for unknown indication | 22 |
| Drug abuse | 6 |
| Bipolar disorder | 5 |
Official FDA Label for DEPAKINE
Official prescribing information from the FDA-approved drug label.